The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Originally identified in Drosophila melanogaster, the Warts(Wts)/Lats protein kinase has been proposed to function with two other Drosophila proteins, Hippo (Hpo) and Salvador (Sav), in the regulation of cell cycle exit and apoptosis. In mammals, two candidate Warts/Lats homologs, termed Lats1 and Lats2, have been described, and the targeted disruption of LATS1 in mice increases tumor formation. Little, however, is known about the function and regulation of human Lats kinases. Here we report that human Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2. Deletion analysis revealed that regulation of Lats1 occurs through the C-terminal, catalytic domain. Within this domain, two regulatory phosphorylation sites were identified by mass spectrometry. These sites, S909 in the activation loop and T1079 within a hydrophobic motif, have been highly conserved during evolution. Moreover, a direct interaction was observed between Mst2 and hWW45, a putative ortholog of Drosophila Sav. These results indicate that Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway. Although the function of this pathway remains poorly understood in mammals, it is intriguing that, in Drosophila, it has been linked to development and tissue homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, LATS1 requires phosphorylation to be active [105] and LATS1 phosphorylation was increased on the non-acetylated, less stable LATS1K751R [104].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [105]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P., Halladay, J., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,637
Active and Inactive Protein Kinases: Structural Basis for Regulation
Johnson, L. N., Noble, M. E. M., & Owen, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81092-2 · Cited by 1,403 · cited 2×
“Interestingly, these sites are located within the activation loop (S909) and a hydrophobic motif (T1079), two domains previously been implicated in the activation of other kinases (Johnson et al., 1996; Tamaskovic et al., 2003).”
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098 · cited 10×
“When expressed in Drosophila, Mst2 was able to rescue the hpomutant phenotype, showing that it can act as a functional ortholog (Wu et al., 2003).”
BackgroundResultInfluentialDammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976 · cited 7×
“These data suggested that Wts/Lats, Sav and Hpo might form a trimeric complex in which Sav functions as an adaptor protein to bring Wts/Lats in close proximity to Hpo (Harvey et al., 2003).”
BackgroundResultInfluentialTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 7×
“…neither the N-terminally located putative UBA domain, a structure believed to bind ubiquitin moieties (Buchberger, 2002), nor the PPXY motifs, previously implicated in mediating the interaction between Wts/lats and Sav in Drosophila (Tapon et al., 2002), were required for this regulation.”
BackgroundResultInfluentialXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Cited by
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
“These proteins form a conserved kinase cassette (Callus et al., 2006; Praskova et al., 2008; Chan et al., 2005) that phosphorylates and inactivates the mammalian Yki homologs YAP (Dong et al.”
BackgroundHippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
“Furthermore, phosphorylation of MOB1 by MST1/2 enhances MOB1 interaction with the autoinhibitory domain of LATS1/2, leading to full activation of LATS1/ 2 (Callus et al., 2006; Chan et al., 2005; Praskova et al., 2004; Wu et al., 2003).”
Huang, J., Wu, S., Barrera, J., Matthews, K., & Pan, D. (2005) · Cell · doi:10.1016/j.cell.2005.06.007 · Cited by 1,863
“Indeed, a recent study has demonstrated the activation of the mammalian Lats1 kinase by the mammalian Hpo homologs Mst1/Mst2 (Chan et al., 2005).”
BackgroundResultThe Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
“Interestingly, Drosophila mutants for Hippo, Warts, and Sav also display increased F-actin levels, suggesting that Hippo signaling and F-actin regulation are deeply untangled in fly tissues.”
BackgroundInfluentialMechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
“However, the exact role of NDR1/2 in Hippo pathway regulation still needs to be further defined, as deletion of LATS1/2 is sufficient to abolish YAP phosphorylation and cause constitutive YAP nuclear localization under most conditions examined (Meng et al. 2015).”
InfluentialThe Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294
“MST1 (also known as STK4) and MST2 (also known as STK3) phosphorylate LATS1 and LATS2 (Ref”
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
“Core Hippo pathway: a kinase cascade MST1/2 are STE20 family protein kinases and can phosphorylate Sav1, Lats1/2, and Mob1 (Wu et al. 2003; Chan et al. 2005; Callus et al. 2006; Praskova et al. 2008).”
BackgroundInfluentialThe Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
“Activation of Mst1/2 leads to phosphorylation and activation of their direct substrates, Lats1/2 (ref”
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
“Current data suggest that the hydrophobic motif of Lats1/2 is phosphorylated by Mst1/2, and the activation loop is autophosphorylated (Fig. 2; Chan et al. 2005).”
BackgroundHippo signaling: growth control and beyond
Halder, G., & Johnson, R. L. (2011) · Development · doi:10.1242/dev.045500 · Cited by 1,060
“2B) (Chan et al., 2005; Dong et al., 2007; Hao et al., 2008; Hirabayashi et al., 2008; Lei et al., 2008; Oka et al., 2008; Praskova et al., 2008; Zhang et al., 2008a; Zhao et al., 2010b; Zhao et al., 2007).”
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
“Interestingly, mammalian homologs exist for most Hippo pathway members (Chan et al., 2005; Tamaskovic et al., 2003), some of which have previously been linked to cancer development (e.”
BackgroundHippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
“…and the ability of Mst1/2 to phosphorylate Lats1/2 and Mob1, as well as Lats1 phosphorylation and inhibition of Yap1, the mammalian ortholog of Yorkie, have been observed in vitro and in cell culture (Chan et al., 2005; Dong et al., 2007; Hao et al., 2008; Praskova et al., 2008; Zhao et al., 2007).”
BackgroundThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis
Zhao, B., Li, L., Wang, L., Wang, C.-Y., Yu, J., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.173435.111 · Cited by 793
“Lats1/2 are activated by phosphorylation of the activation loop (S909/872 for Lats1 and Lats2) and the hydrophobic motif (T1079/999 for Lats1 and Lats2) (Chan et al. 2005).”
BackgroundInfluentialTumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
The Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
“SuperHippo, a designed WWC-derived protein, was shown to inhibit YAP/TAZ activity by inducing the phosphorylation of LATS1/2 due to the requirement of the WWC protein in the activation of LATS1/2.”
BackgroundInfluentialHamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
“All five proteins are highly conserved between flies and vertebrates and, in both systems, Hpo acts upstream of Wt”
BackgroundThe Hippo signaling pathway in stem cell biology and cancer
Mo, J., Park, H. W., & Guan, K. (2014) · EMBO reports · doi:10.15252/embr.201438638 · Cited by 674
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Zhao, B., Li, L., Lu, Q., Wang, L. H., Liu, C.-Y., Lei, Q., & Guan, K.-L. (2011) · Genes & Development · doi:10.1101/gad.2000111 · Cited by 665
“Core to the Hippo pathway is a kinase cascade in which mammalian Mst1/2 kinases (Drosophila Hippo homologs) complexed with a scaffold protein, Sav1, to phosphorylate and activate the Lats1/2 kinases (Chan et al. 2005; Callus et al. 2006).”
BackgroundHippo signaling in organ size control
Pan, D. (2007) · Genes & Development · doi:10.1101/gad.1536007 · Cited by 647
“3B; Chan et al. 2005; Callus et al. 2006; Hergovich et al. 2006).”
The Hippo Pathway Regulates Wnt/β-Catenin Signaling
Varelas, X., Miller, B. W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F. A., Sakuma, R., Pawson, T., Hunziker, W., McNeill, H., et al. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.03.007 · Cited by 569
Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats
Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.-L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 568
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Mo, J.-S., Meng, Z., Kim, Y. C., Park, H. W., Hansen, C. G., Kim, S., Lim, D.-S., & Guan, K.-L. (2015) · Nature Cell Biology · doi:10.1038/ncb3111 · Cited by 557
“Phosphorylation of S909 and T1079 in Lats1 positively correlate with Lats activity 33, 34 .”
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
Meng, Z., Moroishi, T., Mottier-Pavie, V., Plouffe, S. W., Hansen, C. G., Hong, A. W., Park, H. W., Mo, J.-S., Lu, W., Lu, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9357 · Cited by 530
Yu, J., Zheng, Y., Dong, J., Klusza, S., Deng, W.-M., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.12.012 · Cited by 496
“antibody against T1077 of the Wts hydrophobic motif, based on previous reports that Lats1/2 are phosphorylated by Mst1/2 at a conserved site (Chan et al., 2005; Praskova et al., 2008).”
MethodThe Hippo–YAP pathway: new connections between regulation of organ size and cancer
Zhao, B., Lei, Q.-Y., & Guan, K.-L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.10.001 · Cited by 455
“Lats1/2 is phosphorylated by Mst1/2 on the activation loop and hydrophobic motif, possibly with autophosphorylation involved [40].”
Couzens, A. L., Knight, J. D. R., Kean, M. J., Teo, G., Weiss, A., Dunham, W. H., Lin, Z.-Y., Bagshaw, R. D., Sicheri, F., Pawson, T., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004712 · Cited by 441
YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29
Tumaneng, K., Schlegelmilch, K., Russell, R. C., Yimlamai, D., Basnet, H., Mahadevan, N., Fitamant, J., Bardeesy, N., Camargo, F. D., & Guan, K.-L. (2012) · Nature Cell Biology · doi:10.1038/ncb2615 · Cited by 453
MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
Praskova, M., Xia, F., & Avruch, J. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.006 · Cited by 422
Zeng, Q., & Hong, W. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.011 · Cited by 435
“Although the sites on Wts/ LATS1/2 phosphorylated by Hippo/Mst1/2 have been defined (Chan et al., 2005) and Hippo also phosphorylates Mats (Wei et al., 2007), we know little about the phosphatases that dephosphorylate Wts/LATS and/or Yorkie/YAP.”
BackgroundThe Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
YAP regulates neural progenitor cell number via the TEA domain transcription factor
Cao, X., Pfaff, S. L., & Gage, F. H. (2008) · Genes & Development · doi:10.1101/gad.1726608 · Cited by 397
“3328 GENES & DEVELOPMENT We also engineered a kinase-dead mutant of Lats2 (Lats2KD; Chan et al. 2005) as well as an shRNA targeting Lats1 (shLats1) (Supplemental Fig.”
BackgroundMethodInfluentialMst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
Oka, T., Mazack, V., & Sudol, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804380200 · Cited by 367
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Moroishi, T., Park, H. W., Qin, B., Chen, Q., Meng, Z., Plouffe, S. W., Taniguchi, K., Yu, F.-X., Karin, M., Pan, D., et al. (2015) · Genes & Development · doi:10.1101/gad.262816.115 · Cited by 369
“As we observed an increased phosphorylation of LATS1/2 at the HM, a site known to be phosphorylated by MST1/2 (Chan et al. 2005), we investigated whether MST1/2 are responsible for this activation.”
Saucedo, L. J., & Edgar, B. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2221 · Cited by 363
“These components of the signalling cascade are conserved in mammal”
BackgroundRole of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
Boopathy, G. T. K., & Hong, W. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00049 · Cited by 344
Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation
Yu, F.-X., Zhang, Y., Park, H. W., Jewell, J. L., Chen, Q., Deng, Y., Pan, D., Taylor, S. S., Lai, Z.-C., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.219402.113 · Cited by 337
“Activated Lats1/2 in complex with its regulatory protein, Mob, in turn phosphorylates and inhibits YAP and TAZ, two homologous transcription coactivators (Wu et al. 2003; Chan et al. 2005; Huang et al. 2005; Callus et al. 2006; Dong et al. 2007; Zhao et al. 2007; Lei et al. 2008; Oh and Irvine 2008).”
BackgroundFrom Cell Structure to Transcription: Hippo Forges a New Path
Edgar, B. A. (2006) · Cell · doi:10.1016/j.cell.2006.01.005 · Cited by 331
“MST2 (Hippo) for instance, can activate LATS1 (Warts) (Chan et al., 2005), and human Mats homologs (the MOB proteins) have been found to associate with multiple NDR type kinases homologous to Warts (Tamaskovic et al.”
The Hippo pathway in intestinal regeneration and disease
Hong, A. W., Meng, Z., & Guan, K.-L. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.59 · Cited by 326
NDR kinases regulate essential cell processes from yeast to humans
Hergovich, A., Stegert, M. R., Schmitz, D., & Hemmings, B. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1891 · Cited by 323
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Richter, A. M., Pfeifer, G. P., & Dammann, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.004 · Cited by 295
The Hippo signaling pathway and stem cell biology
Ramos, A., & Camargo, F. D. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.04.006 · Cited by 287
Silva, E., Tsatskis, Y., Gardano, L., Tapon, N., & McNeill, H. (2006) · Current Biology · doi:10.1016/j.cub.2006.09.004 · Cited by 290
YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer
Noguchi, S., Saito, A., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113674 · Cited by 277
“MST1/2 in complex with the regulatory protein SAV1 phosphorylate hydrophobic motifs of LATS1/2, which form a complex with the regulatory protein, MOB1 [13].”
BackgroundRegulation of the Hippo–YAP pathway by protease-activated receptors (PARs)
Mo, J.-S., Yu, F.-X., Gong, R., Brown, J. H., & Guan, K.-L. (2012) · Genes & Development · doi:10.1101/gad.197582.112 · Cited by 282
“MST1/2 and Lats1/2 form a kinase cascade to regulate YAP/TAZ phosphorylation (Chan et al. 2005).”
BackgroundCallus, B. A., Verhagen, A. M., & Vaux, D. L. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05427.x · Cited by 276
Shao, D., Zhai, P., Del Re, D. P., Sciarretta, S., Yabuta, N., Nojima, H., Lim, D.-S., Pan, D., & Sadoshima, J. (2014) · Nature Communications · doi:10.1038/ncomms4315 · Cited by 276
“Overexpression of Mst1 enhanced the phosphorylation of Ser 872 and Thr 1041 of Lats2, indicating full activation of Lats2 20 , as well as Ser 127 phosphorylation of YAP (Supplementary Fig.”
Characterization of Hippo Pathway Components by Gene Inactivation
Plouffe, S. W., Meng, Z., Lin, K. C., Lin, B., Hong, A. W., Chun, J. V., & Guan, K.-L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.034 · Cited by 275
“These results demonstrate that LATS1/2 have some intrinsic activity to phosphorylate YAP/ TAZ independent of MOB1A/B, although MOB1A/B are necessary to promote full LATS1/2 activation (Chan et al., 2005; Praskova et al., 2008).”
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Furth, N., & Aylon, Y. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.99 · Cited by 260
“MST-dependent phosphorylations of LATS (S909/T1079 on LATS1 and T1041 on LATS2) increase its kinase activity.(4,27)”
BackgroundDas, A., Fischer, R. S., Pan, D., & Waterman, C. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708313 · Cited by 243
Li, W., Cooper, J., Zhou, L., Yang, C., Erdjument-Bromage, H., Zagzag, D., Snuderl, M., Ladanyi, M., Hanemann, C. O., Zhou, P., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.001 · Cited by 243
“Activated Lats1 then undergoes autophosphorylation at S909 (Chan et al., 2005).”
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
Kim, W., Khan, S. K., Gvozdenovic-Jeremic, J., Kim, Y., Dahlman, J., Kim, H., Park, O., Ishitani, T., Jho, E.-H., Gao, B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88486 · Cited by 244
Disease implications of the Hippo/YAP pathway
Plouffe, S. W., Hong, A. W., & Guan, K.-L. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.01.003 · Cited by 229
“Phosphorylated MOB1 binds to the autoinhibitory region of LATS, enabling LATS phosphorylation and activation [3, 4].”
BackgroundEstrogen regulates Hippo signaling via GPER in breast cancer
Zhou, X., Wang, S., Wang, Z., Feng, X., Liu, P., Lv, X.-B., Li, F., Yu, F.-X., Sun, Y., Yuan, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79573 · Cited by 232
“LATS1/2 are phosphorylated in the activation loop (Ser909/ Ser872 for LATS1/LATS2), which correlates with LATS1/2 activity (44).”
BackgroundProtein kinases of the Hippo pathway: Regulation and substrates
Avruch, J., Zhou, D., Fitamant, J., Bardeesy, N., Mou, F., & Barrufet, L. R. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.07.002 · Cited by 228
“Each of these inputs is linked to a disinct output-in G1, ndr1 phosphorylates p21[S146] (its only known n vivo substrate) promoting p21 degradation; Mst3 appears to be ecessary uniquely for ndr1 activation in G1 [37,137].”
BackgroundThe Hippo Pathway in Heart Development, Regeneration, and Diseases
Zhou, Q., Li, L., Zhao, B., & Guan, K.-L. (2015) · Circulation Research · doi:10.1161/circresaha.116.303311 · Cited by 219
Poon, C. L. C., Lin, J. I., Zhang, X., & Harvey, K. F. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.012 · Cited by 227
Kim, M., Kim, M., Lee, S., Kuninaka, S., Saya, H., Lee, H., Lee, S., & Lim, D. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.102 · Cited by 217
Research progress of mTOR inhibitors
Chen, Y., & Zhou, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112820 · Cited by 197
Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade
Zheng, Y., Wang, W., Liu, B., Deng, H., Uster, E., & Pan, D. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.08.014 · Cited by 219
“Hpo/Mst directly phosphorylates the hydrophobic motif of Wts/Lats (Chan et al., 2005; Wu et al., 2003; Yin et al., 2013; Yu et al., 2010).”
Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
Wei, X., Shimizu, T., & Lai, Z. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601630 · Cited by 205
“Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila”
BackgroundAngiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Paramasivam, M., Sarkeshik, A., Yates, J. R., Fernandes, M. J. G., & McCollum, D. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0300 · Cited by 211
“These studies proposed that angiomotin proteins regulate the Hippo pathway indirectly by binding and sequestering YAP in the cytoplasm.”
BackgroundInfluentialIntegrated Genomic Profiling of Chronic Lymphocytic Leukemia Identifies Subtypes of Deletion 13q14
Ouillette, P., Erba, H., Kujawski, L., Kaminski, M., Shedden, K., & Malek, S. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3105 · Cited by 213
“Given that LATS2 has been implicated in cell cycle progression control, we surmise that Rb, LATS2, and possibly additional, unidentified regulators (in non-del13q14 cases) are regulating this process in different subsets of CLL (44, 45 ).”
BackgroundThe Hippo signaling pathway in development and regeneration
Zhong, Z., Jiao, Z., & Yu, F.-X. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113926 · Cited by 200
LATS tumor suppressor: A new governor of cellular homeostasis
Visser, S., & Yang, X. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13386 · Cited by 202
RASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network
Guo, C., Tommasi, S., Liu, L., Yee, J.-K., Dammann, R., & Pfeifer, G. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.02.055 · Cited by 200
A crucial role of WW45 in developing epithelial tissues in the mouse
Lee, J., Kim, T., Yang, T., Koo, B., Oh, S., Lee, K., Oh, H., Lee, S., Kong, Y., Kim, J., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.63 · Cited by 194
Role of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis
Oh, H. J., Lee, K.-K., Song, S. J., Jin, M. S., Song, M. S., Lee, J. H., Im, C. R., Lee, J.-O., Yonehara, S., & Lim, D.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2951 · Cited by 196
“The cDNAs for Mst1(1-394) and Mst1(1-430) were amplified”
BackgroundThe tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance.
Emoto, K., Parrish, J. Z., Jan, L. Y., & Jan, Y.-N. (2006) · Nature · doi:10.1038/nature05090 · Cited by 194
The human tumour suppressor LATS1 is activated by human MOB1 at the membrane
Hergovich, A., Schmitz, D., & Hemmings, B. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.244 · Cited by 185
“MST1/2 can phosphorylate LATS1/2 in vitro [2], while MST3 targets NDR1/2 [13].”
BackgroundMethodResultInfluentialThe Fat and Warts signaling pathways: new insights into their regulation,mechanism and conservation
Reddy, B. V. V. G., & Irvine, K. D. (2008) · Development · doi:10.1242/dev.020974 · Cited by 187
“2A), including: phosphorylation of Lats (Wts), Mob (Mats) and WW45 (Sav) proteins by Mst (Hpo) kinases (Callus et al., 2006; Chan et al., 2005; Hirabayashi et al., 2008; Praskova et al., 2008); the association of WW45 with Mst and Lats (Callus et al., 2006; Lee et al., 2008); a requirement for WW45…”
BackgroundKIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases
Xiao, L., Chen, Y., Ji, M., & Dong, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.173468 · Cited by 190
Stamenkovic, I., & Yu, Q. (2010) · Current Protein & Peptide Science · doi:10.2174/138920310791824011 · Cited by 170
“Together, these results suggest that MST1/2 and LATS1/2 serve as tumor suppressors in a variety of human cancers.”
BackgroundInfluentialSignaling pathways in hepatocellular carcinoma
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.002 · Cited by 165
Yorkie: the final destination of Hippo signaling
Oh, H., & Irvine, K. D. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.04.005 · Cited by 164
Vichalkovski, A., Gresko, E., Cornils, H., Hergovich, A., Schmitz, D., & Hemmings, B. A. (2008) · Current Biology · doi:10.1016/j.cub.2008.10.060 · Cited by 161
MST kinases in development and disease
Thompson, B. J., & Sahai, E. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201507005 · Cited by 159
“Both MST1 and -2 can phosphorylate and activate the NDR family kinases LATS1 and LATS2 (Chan et al., 2005; Fig.”
Striedinger, K., VandenBerg, S. R., Baía, G. S., McDermott, M. W., Gutmann, D. H., & Lal, A. (2008) · Neoplasia · doi:10.1593/neo.08642 · Cited by 173
“Similar to their Drosophila counterparts, human Mst2 phosphorylates and activates both Lats1 and Lats2 [ 24 ].”
BackgroundChen, Y.-A., Lu, C.-Y., Cheng, T., Pan, S., Chen, H., & Chang, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00060 · Cited by 176
Ni, L., Zheng, Y., Hara, M., Pan, D., & Luo, X. (2015) · Genes & Development · doi:10.1101/gad.264929.115 · Cited by 158
“In addition, the role of Mob1 in Mst1/2-dependent activation of Lats1/2 is unclear.”
BackgroundInfluentialOsmotic stress‐induced phosphorylation by NLK at Ser128 activates YAP
Hong, A. W., Meng, Z., Yuan, H., Plouffe, S. W., Moon, S., Kim, W., Jho, E., & Guan, K. (2016) · EMBO Reports · doi:10.15252/embr.201642681 · Cited by 170
Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma
Seidel, C., Schagdarsurengin, U., Blümke, K., Würl, P., Pfeifer, G. P., Hauptmann, S., Taubert, H., & Dammann, R. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20317 · Cited by 155
Crumbs3-Mediated Polarity Directs Airway Epithelial Cell Fate through the Hippo Pathway Effector Yap
Szymaniak, A. D., Mahoney, J. E., Cardoso, W. V., & Varelas, X. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.06.020 · Cited by 153
“Phosphorylation of Lats1 and Lats2 on Thr1079 and Thr1041, respectively, promotes their activation (Chan et al., 2005).”
BackgroundMechanoregulation and pathology of YAP/TAZ via Hippo and non‐Hippo mechanisms
Dobrokhotov, O., Samsonov, M., Sokabe, M., & Hirata, H. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0202-9 · Cited by 150
“Canonical YAP/TAZ regulation via Hippo pathway The core Hippo pathway starts with MST1/2—STE20 family protein kinases, which phosphorylate hydrophobic motifs of LATS1/2 [20].”
BackgroundYAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
Szulzewsky, F., Holland, E. C., & Vasioukhin, V. I. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2020.12.018 · Cited by 167
Qin, W., Dong, P., Ma, C., Mitchelson, K. R., Deng, T., Zhang, L., Sun, Y., Feng, X., Ding, Y., Lu, X., et al. (2011) · Oncogene · doi:10.1038/onc.2011.561 · Cited by 155
“MST2 is a known tumor suppressor that inhibits AKT1 phosphorylation and activates the human large tumor suppressor kinase, Lats1 (Chan et al., 2005).”
BackgroundAjuba Family Proteins Link JNK to Hippo Signaling
Sun, G., & Irvine, K. D. (2013) · Science Signaling · doi:10.1126/scisignal.2004324 · Cited by 153
Stegert, M. R., Hergovich, A., Tamaskovic, R., Bichsel, S. J., & Hemmings, B. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11019-11029.2005 · Cited by 152
“This suggests that the interaction of MST3 with NDR2 is not stable, similar to the interaction reported between MST1/2 and the NDR relative LATS1/Warts ( 5 , 21).”
ResultThe Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells
Zhou, D., Medoff, B. D., Chen, L., Li, L., Zhang, X.-F., Praskova, M., Liu, M., Landry, A., Blumberg, R. S., Boussiotis, V. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810773105 · Cited by 148
“Moreover, mice lacking LATS1 develop soft tissue sarcomas and ovarian tumors (21).”
BackgroundInfluentialDrosophila models for cancer research
Vidal, M., & Cagan, R. L. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.12.004 · Cited by 163
Furukawa, K. T., Yamashita, K., Sakurai, N., & Ohno, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.032 · Cited by 147
Salah, Z., Melino, G., & Aqeilan, R. I. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3516 · Cited by 150
“These components are highly conserved in mammals (4, 5).”
BackgroundHippo Pathway Regulation of Gastrointestinal Tissues
Yu, F.-X., Meng, Z., Plouffe, S. W., & Guan, K.-L. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071733 · Cited by 136
“Mst1 and -2, and the interaction between Lats1 and -2 and phosphorylated Mob1, leads to Lats1 and -2 activation (11, 24, 25).”
The RASSF1A Tumor Suppressor Activates Bax via MOAP-1
Vos, M. D., Dallol, A., Eckfeld, K., Allen, N. P. C., Donninger, H., Hesson, L. B., Calvisi, D. F., Latif, F., & Clark, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m512128200 · Cited by 148
Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling
Romano, D., Nguyen, L. K., Matallanas, D., Halász, M., Doherty, C., Kholodenko, B. Ν., & Kölch, W. (2014) · Nature Cell Biology · doi:10.1038/ncb2986 · Cited by 151
Boggiano, J. C., & Fehon, R. G. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.03.013 · Cited by 140
Metadata
- Authors
- Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Silljé, Herman H W
- Venue
- Oncogene
- Published
- 2005-01-31
- Volume
- 24
- Issue
- 12
- Pages
- 2076-2086
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2105193974
- Cited by
- 584
- References
- 42
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 41 · 2023: 19 · 2022: 37 · 2021: 39 · 2020: 40 · 2019: 36 · 2018: 39 · 2017: 26 · 2016: 36 · 2015: 35 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Croucher Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- MST2, LATS1, LATS2, Ste20-like kinase, Hippo signaling pathway, Warts kinase, kinase activation, phosphorylation sites, catalytic domain, tumor suppressor kinase, cell cycle regulation, apoptosis
- MeSH terms
- Serine-Threonine Kinase 3, Hippo Kinases, Amino Acid Sequence, Animals, Cell Line, Drosophila melanogaster, Gene Expression Regulation, HeLa Cells, Humans, Kidney, Peptide Fragments, Genes, Tumor Suppressor, Protein Serine-Threonine Kinases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.